Efficacy of the treatment with VANIQA 11,5% creme in patients suffering from hirsutism of the upper lip - Treatment with VANIQA

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-003537-41-DE

Enrollment

Registered

2005-11-02

Start date

2005-10-27

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hirsutism of the upper lip in female patients suffering from increased hair growth in the face

Interventions

Trade Name: Vaniqa 11,5% Cream Product Name: Vaniqa Pharmaceutical Form: Cream INN or Proposed INN: Eflornithine Concentration unit: % percent Concentration number: 11,5-

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: females suffering from hisrsutism of the upper lip Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Other diseases of the skin like alopecia areata, lichen ruber planus, lupus erythematodes, tinea pregnancy females under 18 years of age allergic contact eczema against application of eflorithine no waxing, no plucking of hair

Design outcomes

Primary

Measure	Time frame
Main Objective: efficacy of the cream in the treatment of hirsutism in the face of female patients;Secondary Objective: non;Primary end point(s): Reduction of hairthickness in 4 months using the trichoScan method	—

Countries

Germany

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026